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ABSTRACT: Patients with DM are often afflicted by debilitating urologic 
complications. The main aim of this study is to investigate the effect of 
streptozotocin (STZ)-induced type I diabetes on contractile responses to numerous 
stimuli, intracellular cation concentrations and morphology in the rat.  Adult rats 
(n=12) were humanely killed and detrusor muscles of urinary bladder located and 
excised rapidly and placed in organ baths. Then urinary bladder detrusor muscles 
were blotted, weighed and dissolved in concentrated nitric acid for the measurements 
of cation contents. The diabetic rats had significantly (P<0.05) elevated blood 
glucose compared to control rats.  The contractile responses induced by EFS were 
significantly (P<0.05) increased in the diabetic urinary bladder tissue in comparison 
to the control urinary bladder tissue. The increase in the contractile force was 
calcium-dependent in both control and diabetic urinary bladder tissues. The results 
also showed no significant differences in the levels of sodium, potassium, calcium, 
between the diabetic and control urinary bladder (p>0.05). However, there was a 
significant (P<0.05) decrease in magnesium in the diabetic urinary bladder tissue in 
comparison to the control urinary bladder tissue. The increased responsiveness of the 
diabetic urinary bladder tissue compared to the control tissue may be due to either 
alterations in the intracellular cation concentrations, hypertrophy of the diabetic 
urinary bladder or calcium sensitivity to the myofilaments. The results also raise the 
possibility that that these factors, in conjunction with other causes may work in 
tandem to exacerbate diabetic bladder dysfunction. 
INTRODUCTION: The urologic complications of 
diabetes mellitus, presenting as bladder 
dysfunction, sexual and erectile dysfunction,
 
as 
well as urinary tract infections (UTI) may be held 
responsible for considerable loss of productivity 
and burden on healthcare facilities associated with 
the disease. With DM reaching epidemic 
proportions and still rising, the impact of these 
symptoms have been reported to affect the quality 
of life in equal measures to that of the deadly 
acquired immunodeficiency syndrome.
1  
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In the literature, there is considerable divergence 
with regards to electrophysiological and 
pharmacological studies conducted to identify 
prospective mechanisms underlying bladder 
dysfunction in the diabetic state.  
 
There are contradictory results in EFS-induced 
contractile responses of the diabetic urinary bladder 
tissue relative to the control urinary bladder tissue; 
wherein numerous studies have shown the diabetic 
bladder tissue was more responsive than its control 
counterpart. 
2, 3, 4, 5
 On other hand, others report 
either decreased or little change in EFS-induced 
contractile response. 
6, 7, 8
 In the same vein, 
experiments measuring contractile responses of the 
bladder to exogenous muscarinic agonists have also 
produced contradictory results.
9, 10, 11
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With regards to responses to EFS, a number of 
theories have been postulated and subsequently 
disproved. Belis et al (1997), theorise that the 
difference in contractile responses in diabetics 
compared to control is due to increased calcium 
(Ca
2+
) channel activity but in 2000, Waring and 
Wendt found no supporting evidence and postulate 





 Tong et al
 
(1999) suggested the 
increase in EFS-induced contractile responses were 
due to increased muscarinic receptor density 






morphological studies are indicative of a 
progressive hypertrophy of the urothelium of the 
urinary bladder in diabetes.
14, 15
 However, the 
importance of this on the mechanisms of urologic 
complications remains ill understood.   
 
Such variability in the observations suggests a 
complex multi-factorial aetiology of diabetes-
induced bladder dysfunction. Therefore, the aim of 
this study was to investigate the effects of the 
contractile response to EFS, atropine and 
verapamil. Furthermore, the same stimulatory 
parameters were assessed in the presence of 





]0. In addition, morphological 
studies of the urinary bladder were also conducted.   
 
The main aim of the comparative study is to 
investigate the role of cations contents compared to 
the age matched control. 
 
MATERIALS AND METHODS: 
General Procedures: 
All experiments were done using male Wistar rats 
weighing between 151.1-174.3 ± 1.54 g.  One 
group of animals were rendered diabetic with a 
single intraperitoneal injection of STZ (60 mg/kg 
body weight) dissolved in citrate buffer (pH 4.5). 
Age-matched control rats received 0.3 ml of the 
citrate buffer alone. The rats were tested for 
diabetes 4-5 days after injection and on the day 
when they were used for experiments using a 
glucose meter. 
  
The rats were humanely killed by a blow to the 
head followed by cervical dislocation.  An incision 
was made in the lower abdomen and the urinary 
bladder was located and rapidly excised at the 
urethra, blotted and weighed.  Subsequently the 
bladder was placed in a Krebs-Henseleit (KH) 
solution.  In experiments involving the perturbation 
of [Ca
2+
]0, the same chemical composition of KH 
was utilised, with the exception of the Ca
2+
 
chloride; which was altered to 1.25 mM and 5.00 
mM to achieve low and high [Ca
2+
]0, respectively. 
The extracellular concentration of 2.56 mM Ca
2+
 
was used as the control in these experiments. The 
study had the relevant ethical clearance from the 
Faculty of Science and Technology Ethics 
Committee.     
 
Bladder Contractility Experiments: 
The tissue was gently cut into 10mm long strips, 
subsequently, the urinary bladder was cleansed 
thoroughly and one end of the tissue was tied to a 
hook on the electrode, whilst the other end was tied 
to an isometric transducer (Model). The tissue was 
then mounted in the organ bath containing KH 
solution and kept at a constant temperature of 37
0
C. 
The pH was maintained at 7.4 and the solution was 
gassed continuously with 95% oxygen and 5% 
carbon dioxide. The changes in contractions were 
measured by an isometric transducer coupled to a 
preamplifier and subsequently an oscilligraph. 
 
After the tissue stabilized following 1 g calibration, 
EFS-induced contractions were investigated by 
using two parallel silver wire electrodes connected 
to a current amplifier and pulse generator. EFS was 
induced for a period of 10 seconds at a range of 
frequencies ranging from 1-100 Hz at 50 volts with 
1 msec pulse. The same procedure was repeated in 
the presence of 10
-4
 M atropine and 10
-4
 M 
verapamil. The bladder tissue was incubated for 20 
minutes in the required antagonists prior to 
stimulation. The same series of experiments with 
the addition of 10
-4
 M acetylchline (ACh) were 
conducted in low (1.25 mM) and high (5.00 mM) 
extracellular Ca
2+
 concentration. The KH solution 
was replaced and the urinary bladder tissue was 
allowed to rest for 30 minutes after each series of 
stimulation. The contractile responses are 
expressed as grams/cross sectional area.  The cross 
sectional area was established by mass x 
(length/density), whereby the density was 
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Measurement of Cations: 
The tissue was dissolved in 1 ml of concentrated 
nitric acid and a volume of 0.2 ml was diluted in 
9.8 ml of de-ionized water. The samples were then 










).  The corning flame photometer 




, whilst an atomic 





. The required standard ion 
solutions ranging from 5-20 mg/ml were used to 
produce standard curves required to calculate the 
ion content. All the values are expressed in mM 
(100 mg tissue) 
1
.   
 
Statistical Analysis: 
Results are given as a Mean ±Standard Error of the 
Mean (SEM).  Statistical analysis was performed 
by using either independent student t test and 
Student’s paired t tests.  The P value less than 0.05 
was considered significant (P<0.05), in contrast, a 
P value greater than 0.05 was considered 
insignificant (P>0.05). 
 
RESULTS AND DICUSSION: 
General Characteristics: 
On arrival in the laboratory, the male Wistar rats 
weighed 188.13±2.46 g on average but following 
the introduction of STZ, the diabetic rats gained 
significantly less (P<0.05) weight than age-
matched controls (Table 1).  The mean plasma 
glucose concentration was elevated by almost five 
times in the diabetic group of rats relative to the 
control rats. The diabetic rats also exhibited the 
classical symptoms of diabetes, such as polydipsia, 
polyphagia and polyurea. 
 
TABLE 1: GENERAL CHARACTERISTICS OF 12-14 WEEK DIABETIC AND AGE-MATCHED CONTROL URINARY 
BLADDER. NOTE THE SIGNIFICANT INCREASE (*P<0.05) IN BLOOD GLUCOSE AND THE DECREASE (P<0.05) IN 
WEIGHT GAINED IN THE DIABETIC RATS IN COMPARISON TO THE CONTROL RATS. 
Parameters N Control Diabetic 
Weight of Animals on Arrival (g) 24 188.13 ± 2.46 - 
Weight of Animals on Day of Experiment (g) 12 552.20 ± 12.79 289.00 ± 8.36
*
 
Blood Glucose (mM) 12 5.62 ± 0.21 26.84 ± 1.06
*
 




Response to EFS: 
A frequency-dependent response in the EFS-
induced contractions in the control and diabetic 
urinary bladder tissue is shown in Fig.1. The force 
of contraction induced by EFS was significantly 
(P<0.05) greater in the diabetic urinary bladder 
tissue in comparison to the control urinary bladder 
tissue. The presence of atropine and verapamil 
caused significant (P<0.05) reductions in both 
groups of the urinary bladder tissue. Both, atropine 
and verapamil failed to completely abolish EFS-
induced contractile responses in the control and 
diabetic bladder strips. 
 
FIG. 1: EFS-EVOKED CONTRACTILE RESPONSES OF URINARY BLADDER STRIPS IN AGE-MATCHED CONTROL (OPEN 
CIRCLES) AND STZ-INDUCED (OPEN TRIANGLES) DIABETIC RATS. DATA ARE THE MEAN±SEM, n=6, (* P<0.05). 
Sangar et al., IJPSR, 2016; Vol. 7(6): 2435-2443.                                        E-ISSN: 0975-8232; P-ISSN: 2320-5148 
International Journal of Pharmaceutical Sciences and Research                                                                              2438 
Extracellular calcium-dependent responses: 
EFS and ACh-induced contractile force appeared to 
be a function of extracellular Ca
2+
 concentration in 
both groups. i.e. the force of contraction induced by 
EFS was greater in the presence of high 
extracellular concentration of Ca
2+
 concentration 
compared to the control extracellular concentration 
of Ca
2+
. The similar pattern was also seen in 




FIG.2: BAR SHOWS THE EFFECT OF 10-4 M ACh ON CONTRACTIONS IN AGE-MATCHED CONTROL (C) AND STZ-








 (Fig.3) decreased in the 
un-stimulated diabetic urinary bladder tissues in 
comparison to the healthy age-match control 
urinary bladder although the correlation failed to 
achieve significance (P>0.05. A slight increase was 
observed in the concentration of Ca
2+
 in the un-
stimulated diabetic urinary bladder tissue in 
comparison to controls (Fig. 4). However, the 
difference was not statistically significant (P>0.05). 
The results showed the level of Mg
2+
 decreased 
significantly (P<0.05) in un-stimulated diabetic 
urinary bladder tissue in comparison to un-
stimulated healthy age-match control urinary 
bladder tissue (Fig. 5). 
 
FIG. 3: BAR SHOWS THE CONCENTRATION OF Na+ IN CONTROL AND DIABETIC STIMULATED AND NON-
STIMULATED URINARY BLADDER TISSUE. THE RESULTS SHOW THAT IN BOTH CONTROL AND DIABETIC TISSUES, 
THE LEVELS OF NA+ DECREASED SIGNIFICANTLY (*P<0.05) AFTER STIMULATION COMPARED TO NON-
STIMULATED TISSUES. EACH BAR IS REPRESENTED AS THE MEAN±SEM n=5.  Note that A has significantly (*P<0.05) more 
Na+ than B and D.  C has significantly (*P<0.05) more Na+ than D 
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FIG.4: BAR SHOWS THE CONCENTRATION OF Ca2+ IN CONTROL AND DIABETIC STIMULATED AND NON-
STIMULATED URINARY BLADDER TISSUE. THE RESULTS SHOW THAT IN BOTH CONTROL AND DIABETIC TISSUES, 
THE LEVELS OF Ca2+ DECREASED SIGNIFICANTLY (*P<0.05) AFTER STIMULATION COMPARED TO NON-
STIMULATED TISSUES. EACH BAR IS REPRESENTED AS THE mean±SEM n=5.  Note that A has significantly (*P<0.05) more 
Ca2+ than B and D.  C has significantly (*P<0.05) more Ca2+ than D. 
 
FIG.5: BAR SHOWS THE CONCENTRATION OF Mg2+ IN CONTROL AND DIABETIC STIMULATED AND NON-
STIMULATED URINARY BLADDER TISSUE.  THE RESULTS SHOW A SIGNIFICANT (*P<0.05) DECREASE IN THE 
CONCENTRATION OF Mg2+ IN THE DIABETIC URINARY BLADDER TISSUE IN COMPARISON TO THE CONTROL 
TISSUE.  MOREOVER, IN BOTH CONTROL AND DIABETIC TISSUES, THE LEVELS OF Mg2+ DECREASED 
SIGNIFICANTLY (*P<0.05) AFTER STIMULATION COMPARED TO NON-STIMULATED TISSUES. EACH BAR IS 
REPRESENTED AS THE MEAN±SEM n=5. Note that A has significantly (*P<0.05) more Mg2+ than B, C and D.  C has significantly 
(*P<0.05) more Mg2+ than D. 
 
FIG.6: REPRESENTS IMAGES OF HAEMATOXYLIN AND EOSIN STAINED SECTIONS OF (A) DIABETIC URINARY 
BLADDER, (B) CONTROL URINARY. THE MICROGRAPHS ARE REPRESENTATIVE OF 3 SUCH EXPERIMENTS. 
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The results of this study have demonstrated marked 
changes in the characteristics, EFS-evoked 
contraction, cation levels and the morphology of 
STZ-induced diabetic rats compared to controls.  
 
In this study, numerous observations were made on 
the general characteristics of both control and STZ-
induced diabetic rats were made. On arrival in the 
laboratory, the male Wistar rats weighed 
188.13±2.46 g on average. Following the injection 
of STZ, the diabetic rats gained significantly less 
(P<0.05) weight than age-matched healthy rats over 
the experimental periods of 12-14 weeks.  In 
addition, the plasma glucose concentrations were 
significantly elevated in the diabetic group 
compared to the control. These observations 
together with other characteristic changes of the 
STZ-induced diabetic rat including polyuria, 
polydipsia and signs of cataract are indicative of 
the consistency and effectiveness of STZ- in 
inducing type-1 diabetes in the rat. 
 
Despite the increase in the weight of the diabetic 
animals, the study also showed that the urinary 
bladder in the diabetic rats was considerably larger 
with increased mass. The increased size could be a 
result of either hypertrophy or hyperplasia, 
however, both, increased size and mass are thought 
to compensate for the increase in urine 
production.
3, 16
 Another interesting observation 
seen in the STZ-induced diabetic rat was the 
substantial increase in the quantity of urine in the 
urinary bladder the time of excision in comparison 
to that of the healthy rat.  This could suggest that 
diabetic rats do not urinate as frequently as healthy 
rats or they have an increased residual volume of 
urine. Alternatively, the urinary bladder may fill up 
with urine a lot faster than their control 
counterparts, an observation made previously by 




EFS has proven to be an effective physiological 
tool to excite intrinsic nerves and to assess 
contractile and secretary responses to endogenous 
neurotransmitter release in various tissues.
18
 The 
results of this study have shown that EFS elicits 
frequency-dependant contractile response in the 
both control and diabetic tissues and the contractile 
responses are significantly (P<0.05) greater in the 
diabetic tissue in comparison to control urinary 
bladder tissue. These results are in agreement with 




contractions are mediated by muscarinic receptors, 
namely M2 and M3 receptors although M1, M4 and 
M5 muscarinic receptors are also present in the rat 
detrusor muscle. 
20, 21
 The signalling mechanisms 
for muscarinc receptors vary amongst the different 
subtypes and species and have yet to be completely 
understood. Nevertheless, it is thought M2 receptors 
inhibit adenyl cyclase by reducing cAMP 
concentrations via the Gi family of proteins, whilst 
M3 receptors exert the effects through the Gq family 




The optimum frequency for the production of 
maximal force of contraction differed for control 
and diabetic urinary bladder tissue. EFS at 10 HZ 
evoked maximal contractile force whereas 20 Hz 
appeared to the optimal frequency for diabetic 
urinary bladder tissue. Results indicate that EFS-
induced contractions were significantly (P<0.05) 
greater in the diabetic urinary bladder tissue in 
comparison to age-matched control tissue. These 
results are in agreement with the findings of 




 In contrast, other previous studies have 
shown little or no change in EFS-induced 
contractile force of the diabetic urinary bladder 
relative to controls. In two other studies by 
Longhurst and Belis (1986) and Ichiyanagi et al 
(2002) a decrease in contractile force in the diabetic 





No clear reason for the discrepancies in published 
results has been ascertained, however, it is thought 
a poor or a complete lack of standardization in the 
contractile force generated may be to blame.
5
 In 
addition, discrepancies may arise due to inadequate 
experimental protocols i.e. usage of different 
regions of the urinary bladder tissue between both 
groups, or the length and severity of the disease. 
This could have implications on the amount of 
muscarinic receptors present, potentially causing 
changes in the amount of neurotransmitter release; 
naturally affecting the contractile force generated.  
Furthermore, a study conducted by Bezuijen and 
colleagues showed that the differences in the 
contractile force could be attributed to an enlarged 
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bladder size.
23
 This may explain the contradictory 
nature of the results found in the literature. 
However, the overall consensus remains that 
diabetes is associated with enhanced contraction of 
the urinary bladder compared to controls. 
 
The mechanism for the increased contractile force 
generated by EFS in the diabetic urinary bladder 
tissue in comparison to the control bladder tissue 
has yet to be identified, but could be due to the 
increased density of muscarinic receptors or altered 
sensitivity to neurotransmitters.
8, 24, 25
 Indeed, the 





reported significant increases in the quantity of M3 
mAChR protein in the STZ-induced diabetic rat 
urinary bladder in comparison to the control 
urinary bladder. Interestingly, Tong et al
 
(1999) 
also demonstrated an upregulation in M2 receptor 
mRNA.
13
 Nevertheless, its significance in diabetes 
bladder dysfunction remains ill understood. 
Another potential mechanism for altered properties 
of the diabetic urinary bladder tissue could be due 
to impaired nitric oxide control.
26
 These 
observations reiterate the complex multifactorial 
aetiology of diabetes-induced bladder dysfunction.   
 
The results of the study have shown that the 
cholinergic muscarinic antagonist atropine can 
markedly reduce the EFS-evoked contraction in 
both control and diabetic bladder tissues indicating 
that the endogenous neurotransmitter released 
during EFS is Ach. The finding that atropine failed 
to completely abolish EFS-evoked contractions in 
both age-matched control and diabetic urinary 
bladder tissue is suggestive of the action of 





The NANC-mediated response seen in this study is 
negligible in comparison to the total EFS-induced 
contraction, complementing the results found by 
Sjörgren et al (1982).
28
  The results so far indicated 
that EFS can induce contractions via the release of 
ACh from intrinsic nerves, it was relevant to 
ascertain whether exogenous application of ACh 
can elicit urinary bladder contractions. The results 
indicate that Ach can evoke contractions in both 
groups in a dose dependent manner. There was no 
significant (p> 0.05) differences in the contractile 
responses generated between the control and 
diabetic urinary bladder tissue. However, the Ach-
evoked force of contraction was substantially lower 
than EFS-induced contractions. As expected, Ach-
induced contractions diminished but were not 
completely abolished in the presence of atropine, 
suggesting a small number of muscarinic receptors 
are resistant to atropine. 
 
The increase in the force of contraction of diabetic 
bladder tissue compared to control following EFS 





 plays a vital role in the ECC 
process whereby it initiates and promotes muscle 
contraction.
29
 Therefore, it was decided to 
investigate the effects of varying [Ca
2+
]o on both  
EFS and ACh evoked contraction. The results show 
that the EFS-evoked force of contraction of both 
diabetic and control bladder tissue was dependent 
upon [Ca
2+
]o. In both control (2.56 mM) and 
elevated 5.00 mM [Ca
2+
]o, there were significant 
increases in force compared to the responses 
obtained in low 1.4mM  [Ca
2+
]o The force of 
contraction in response to applications of 
exogenous 10
-4
 M Ach were not significantly 
(p>0.05) different in the presence of either 1.25 
mM or 5mM [Ca
2+
]o in the control urinary bladder 
tissue. However, in the diabetic urinary bladder, 
there was a significant (p<0.05) decrease in 
contraction with 1.25 mM [Ca
2+
]o compared to 2.56 
mM and 5.00 mM [Ca
2+
]o. It is possible that the 
diabetic urinary bladder tissue is more sensitive to 
Ca
2+ 
compared to control tissue which in turn could 
be held responsible for the increase in contraction. 
 








 were measured in EFS-evoked stimulated 
and non-stimulated control and diabetic bladder 
tissues. The rationale was to determine whether non 
stimulated tissues contain more cations compared 
to stimulated tissue.  
 
The results show that non-stimulated tissue 









 compared to EFS-evoked stimulated tissues. 





 in control and diabetic 
unstimulated or EFS-evoked stimulated muscle 
tissue. In contrast, the levels of Mg
2+ 
decreased 
significantly in both unstimulated and stimulated 
diabetic tissues compared to controls.  In 
Sangar et al., IJPSR, 2016; Vol. 7(6): 2435-2443.                                        E-ISSN: 0975-8232; P-ISSN: 2320-5148 
International Journal of Pharmaceutical Sciences and Research                                                                              2442 
comparison, the levels of Ca
2+
 increased in the 
diabetic non stimulated and EFS-evoked stimulated 
bladder tissue compared to control. It is well 







is a natural antagonist for Ca
2+
. In the 
presence of low Mg
2+ 






The decrease in levels of the four cations following 
stimulation may be due to damage of the muscles 
during EFS which can be quantified by measuring 
levels of lactate dehydrogenase (LDH) in the 
bathing medium. Alternatively leaching of cations 
from tissues into the bathing medium may be 
another possible explanation. In previous studies, 
we have demonstrated an increase in lactate 
dehydrogenase in the bathing medium following 
EFS. Morphological studies have demonstrated that 
the diabetic urinary bladder tissue exhibits a large 
increase in the number of smooth muscle and 
urothelial cells compared to control tissue. 
 
The results of morphological analysis showed that 
the diabetic urinary bladder tissue had visually, 
more smooth muscle and urothelium in comparison 
to age-matched control urinary bladder tissue. 
However, these experiments fail to use any form of 
image analysis.  Therefore, more accurate 
morphological studies are required.  Nevertheless, 
the results of histology, in the context of the wider 
question, suggest differences in the contractile 
responses may be due to either increased quantity 
of urothelium or smooth muscle mass. The results 
of the study conducted by Pinna and colleagues
14
 
suggest that the diabetic urinary bladder in part, 
requires prostaglandin release from the urothelium 
to activate purinergic receptors. Implying the 
increased urothelium mass may play a role in the 
abnormalities seen in this, and many other studies 
employing the diabetic urinary bladder tissue. The 
importance of the increased smooth muscle layer of 
the diabetic urinary bladder tissue is not as clear as 
the urothelial layer.   
 
CONCLUSION: The results of this study indicate 
the diabetic urinary bladder tissue produced 
significantly increased contractile force in 
comparison to the control urinary bladder tissue. In 
addition, the contractile responses of the urinary 
bladder are mediated by muscarinic receptors and 
are Ca
2+
dependant. The were no significant 
differences in the intracellular cation 
concentrations of sodium, potassium, Ca
2+
 and 
copper, but the diabetic urinary bladder tissue has 
significantly less Mg
2+
 as compared to the healthy 
age-matched control urinary bladder tissue.  
 
The study in its entirety, suggests the marked 
differences in the contractile force of the diabetic 
urinary bladder tissue may be due to altered 
sensitivity to Ca
2+
, decreased intracellular cation 
concentrations and morphological changes to the 
diabetic urinary bladder.  Further more intricate 
studies are required to not only to understand the 
link between these parameters and diabetic bladder 
dysfunction but also the underlying mechanisms 
causing changes in these parameters.  Ultimately, 
allowing for new innovative and effective treatment 
options for diabetes-induced urologic 
complications.     
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